Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:35 PM
Ignite Modification Date:
2025-12-24 @ 2:35 PM
NCT ID:
NCT00320359
Eligibility Criteria:
Inclusion Criteria:
* Evaluable extensive small cell lung cancer, extensive disease.
* Eastern Cooperative Oncology Group (ECOG) performance status \< 2.
* Life expectancy \> 3 months.
* Fit to receive any of the treatments.
* No prior chemotherapy.
* Written informed consent.
Exclusion Criteria:
* Extensive disease treatable with radiotherapy.
* Past or current history of other malignant disease.
* Prior chemotherapy.
* Pregnancy, lactating or lack of effective contraception.
* Concurrent severe medical problems other than small cell lung cancer.
* Patients with central nervous system metastases receiving more than 12 mg /day dexamethasone or equivalent to control symptoms.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00320359
Study Brief:
Protocol Section:
NCT00320359